Furthermore, it may function as a potential biomarker for PD-L1 expression in lung cancer patients.[17] These studies indicated that microRNAs may be related to the progression of cancer, and their mechanisms may take part in the pathogenesis of tumor via controlling cancer-associated genes. This evidence concerns the gene CD274 and lung carcinoma.